Back
Calamos Global Total Return Fund Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Sell
48
CGO
Calamos Global Total Return Fund
Last Price:
$11.08
Seasonality Move:
2.02%
Sell
32
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.51
Seasonality Move:
-18.07%
Sell
48
Calamos Global Total Return Fund (CGO)
is a Sell
Is Calamos Global Total Return Fund a Buy, Sell or Hold?
-
The current Calamos Global Total Return Fund [CGO] share price is $11.03. The Score for CGO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
CGO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.71. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CGO Stock Price Chart
What is Calamos Global Total Return Fund's stock price today?
-
The Calamos Global Total Return Fund share price today is $11.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGO is experiencing selling pressure, which indicates risk of future bearish movement.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
CGO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 34.21 | Sell |
| Chaikin Money Flow: | -11431 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.09 - 11.49) | Sell |
| Bollinger Bands (100): | (11.41 - 12.09) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 45.61 | Sell |
| Chaikin Money Flow: | -20975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.65) | Sell |
| Bollinger Bands (100): | (12.3 - 15.28) | Sell |
CGO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.33 | Sell |
| 20-day SMA: | 11.25 | Sell |
| 50-day SMA: | 11.61 | Sell |
| 200-day SMA: | 11.32 | Sell |
| 8-day EMA: | 11.26 | Sell |
| 20-day EMA: | 11.33 | Sell |
| 50-day EMA: | 11.52 | Sell |
| 200-day EMA: | 11.49 | Sell |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.32 | Sell |
| 20-day SMA: | 11.56 | Buy |
| 50-day SMA: | 12.92 | Sell |
| 200-day SMA: | 11.86 | Sell |
| 8-day EMA: | 12.05 | Sell |
| 20-day EMA: | 12.05 | Sell |
| 50-day EMA: | 12.68 | Sell |
| 200-day EMA: | 12.23 | Sell |
Calamos Global Total Return Fund Earnings Growth & CGO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Calamos Global Total Return Fund Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||